Participants:
Joel Kralj, Director, Platform Innovation, Think Bioscience
Dan Weaver, President, Boulder BioConsulting
Information:
Think Biosciences utilizes an innovative biosynthetic platform to identify small molecule inhibitors against challenging protein targets. This synthetic platform presents unique informatics system requirements to support and accelerate their drug discovery projects. To rapidly overcome the informatics hurdles while maintaining cost-efficiency, Think partnered with Boulder BioConsulting (BBC). BBC is a life science informatics consulting company specializing in solutions and services for small- and mid-sized pharma and biotech enterprises. Through the “Informatics as a Service” approach, Think Biosciences and BBC jointly identified L7 Informatics as the ideal foundation to address Think’s use case.
This talk will describe Think Bioscience’s novel platform, explore their successful collaboration with Boulder BioConsulting, and elaborate on the process used to identify L7 Informatics as the optimal solution. The presentation will showcase how this three-way partnership culminated in the swift and efficient delivery of Think Biosciences’ desired informatics solution. Attendees will also gain insights into the power of “Informatics as a Service” in catalyzing groundbreaking advancements within the biotech industry.
To access this resource, please make sure to accept cookies.